Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001140361-20-005062
Filing Date
2020-03-06
Accepted
2020-03-06 16:12:38
Documents
4
Effectiveness Date
2020-03-06

Document Format Files

Seq Description Document Type Size
1 S-8 forms8.htm S-8 75501
2 EXHIBIT 5.1 ex5_1.htm EX-5.1 7953
3 EXHIBIT 23.2 ex23_2.htm EX-23.2 2045
4 image-ex5_1.jpg GRAPHIC 138739
  Complete submission text file 0001140361-20-005062.txt   277549
Mailing Address 350 FIFTH AVENUE SUITE 7530 NEW YORK NY 10118
Business Address 350 FIFTH AVENUE SUITE 7530 NEW YORK NY 10118 646-440-9100
ROCKET PHARMACEUTICALS, INC. (Filer) CIK: 0001281895 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-236946 | Film No.: 20694903
SIC: 2834 Pharmaceutical Preparations